Bloodstream infections in hospitalized adults with sickle cell disease: A retrospective analysis

American Journal of Hematology

Volumn 81, Issue 10, 2006, Pages 723-728

  Chulamokha, Lalita ^a,b   Scholand, Stephen J ^a   Riggio, Jeff M ^a   Ballas, Samir K ^a   Horn, David ^a   DeSimone, Joseph A ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Division of Infectious Diseases of the Department of Medicine   (United States)

Author keywords

Bacteremia; Bloodstream infection; Catheter infections; Sickle cell disease; Staphylococci

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; FLUCONAZOLE; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; VANCOMYCIN;

ADULT; ANAEROBIC BACTERIUM; ANAEROBIC INFECTION; ANTIMICROBIAL THERAPY; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOOD CULTURE; BLOOD DISEASE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; CRITICAL ILLNESS; FEMALE; FUNGUS CULTURE; FUNGUS ISOLATION; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; GRAM POSITIVE BACTERIUM; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INDWELLING CATHETER; MALE; MEDICAL RECORD; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; MYCOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SEPTICEMIA; SICKLE CELL ANEMIA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; YEAST;

ADULT; AGED; ANEMIA, SICKLE CELL; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BACTEREMIA; CROSS INFECTION; FEMALE; FUNGEMIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33749558934     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20692     Document Type: Review

References (40)

1. Henrick JB. Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. Arch Intern Med 1910;6:517-521.
2. Barrett-Connor E. Bacterial infection and sickle cell anemia. Medicine 1971;50(2):97-112.
3. Leikin SL, Gallagher D, Kinney TR, et al. Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease. Pediatrics 1989;84(3):500-508.
4. Pearson HA. Sickle cell anemia and severe infections due to encapsulated bacteria. J Infect Dis 1977;136:S25-S30.
5. Powars DR. Natural history of sickle cell disease-the first ten years. Semin Hematol 1975;12:267-285.
6. Rogers DW, Clarke JM, Cupidore L, et al. Early deaths in Jamaican children with sickle cell disease. Br Med J 1978;i:1515-1516.
7. Thomas AN, Pattison C, Serjeant GR. Causes of death in sickle-cell disease in Jamaica. Br Med J 1982;285:633-635.
8. Zarkowsky HS, Gallagher D, Gill FM, et al. Bacteremia in sickle hemoglobinopathies. J Pediatr 1986;109(4):579-585.
9. McIntosh S, Rooks Y, Ritchey AK, Pearson HA. Fever in young children with sickle cell disease. J Pediatr 1980;96(2):199-204.
10. Brozovic M, Davies SC, Brownell AI. Acute admissions of patients with sickle cell disease who live in Britain. Br Med J (Clin Res Ed) 1987;294(6581):1206-1208.
11. Woods K, Karrison T, Koshy M, et al. Hospital utilization patterns and costs for adult sickle cell patients in Illinois. Public Health Rep 1997;112(1):44-51.
12. Athale UH, Chintu C. Clinical analysis of mortality in hospitalized Zambian children with sickle cell anaemia. East Afr Med J 1994;71(6):388-391.
13. Norris CF, Smith-Whitley K, McGowan KL. Positive blood cultures in sickle cell disease: time to positivity and clinical outcome. J Pediatr Hematol Oncol 2003;25(5):390-395.
14. Onwabalili JK. Sickle cell disease and infection. J Infect 1983;7(1):2-20.
15. Gill FM, Sleeper AS, Weiner SJ, et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. Blood 1995;86(2):776-783.
16. Aken'ove YA, Bakare RA, Okunade MA. Septicaemia in sickle cell anaemia patients: the Ibadan experience. Cent Afr J Med 1998;44(4):102-104.
17. Okuonghae HO, Nwankwo MU, Offor EC. Pattern of bacteraemia in febrile children with sickle cell anaemia. Ann Trop Paediatr 1993;13(1):55-64.
18. Wierenga KJJ, Hambleton IR, Wilson RM, et al. Significance of fever in Jamaican patients with homozygous sickle cell disease. Arch Dis Child 2001;84:156-159.
19. Workman MR, Philpott-Howard JN, Casewell MW, Bellingham AJ. Salmonella bacteraemia in sickle cell disease at King's College Hospital: 1976-1991. J Hosp Infect 1994;27(3):195-199.
20. Lobel JS, Bove K. Clinicopathologic characteristics of septicemia in sickle cell disease. Am J Dis Child 1982;136(June):543-547.
21. Magnus SA, Hambleton IR, Moosdeen F, Serjeant GR. Recurrent infections in homozygous sickle cell disease. Arch Dis Child 1999;80(6):537-541.
22. Overturf GD, Powars D, Baraff LJ. Bacterial Meningitis and septicemia in sickle cell disease. Am J Dis Child 1977;131(7):784-787.
23. Wright J, Thomas P, Serjeant GR. Septicemia caused by Salmonella infection: an overlooked complication of sickle cell disease. J Pediatr 1997;130(3):394-399.
24. Hord J, Byrd R, Stowe L, et al. Streptococcus pneumoniae sepsis and meningitis during the penicillin prophylaxis era in children with sickle cell disease. J Pediatr Hematol Oncol 2002;24(6):470-472.
25. Platt OS, Brambilla D, Rosse WF, et al. Mortality in sickle cell disease-life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-1644.
26. Wong WY, Powars DR, Chan L, et al. Polysaccharide encapsulated bacterial infection in sickle cell anemia: a thirty year epidemiologic experience. Am J Hematol 1992;39(3):176-182.
27. Powers D, Overturf G, Weiss J, et al. Pneumococcal septicemia in children with sickle cell anemia. Changing trend of survival. J Am Med Assoc 1981;245(18):1839-1842.
28. Overturf GD. Infections and immunizations of children with sickle cell disease. Adv Pediatr Infect Dis 1999;14:191-218.
29. Quinn CT, Rogers ZR, Buchanan GR. Survival of children with sickle cell disease. Blood 2004;103(11):4023-4027.
30. Babiker MA. Prophylaxis of pneumococcal infection in sickle-cell disease by the combined use of vaccination and penicillin. Ann Trop Paediatr 1986;6(3):179-181.
31. Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia: a randomized trial. N Engl J Med 1986;314:1593-1599.
32. Grace CJ, Leiberman J, Pierce K, Littenberg B. Usefulness of blood culture for hospitalized patients who are receiving antibiotic therapy. Clin Infect Dis 2001;32:1651-1655.
33. Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997;24:584-602.
34. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for Nosocomial infections 1988. Am J infect Control 1988;16:128-140.
35. Halasa N, Shankar SM, Talbot TR, et al. Decreased incidence of invasive pneumococcal disease in persons with sickle cell anemia. Poster Abstract 977. IDSA meeting October.
36. Phillips G, Slingluff C, Hartman J, et al. Totally implantable intravenous catheters in the management of sickle cell anemia. Am J Hematol 1988;29(3):134-138.
37. McCready CE, Doughty HA, Pearson TC. Experience with the Port-A-Cath in sickle cell disease. Clin Lab Haematol 1996;18(2):79-82.
38. Abdul-Rauf A, Gauderer M, Chiarucci K, Berman B. Long-term central venous access in patients with sickle cell disease. Incidence of thrombotic and infectious complications. J Pediatr Hematol Oncol 1995;17(4):342-345.
39. Jeng MR, Feusner J, Skibola C, et al. Central venous catheter complications in sickle cell disease. Am J Hematol 2002;69:103-108.
40. Fridkin SK. Candidemia is costly-plain and simple. Clin Infect Dis 2005;41:1240-1241.